MTVAMetaVia Inc.

MTVA Stock Price, Valuation & Chart | MetaVia Inc.

Compare

$1.820+0.10 (+5.81%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology MTVA intrinsic value MTVA calculated fair value vs price

Overview Financials Dividends Ratios

MTVA Historical price chart

MTVA Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization4.01M

PE Ratio-1.15

EPS-1.58

Trading Volume79.42K

Today's High/Low1.84/1.71

Dividend Yield0.00

52 Week High/Low19.03/0.97

Shares Outstanding2.20M

MTVA Financial Statement

MTVA Analyst ratings

MTVA Analysis & performance metrics

MTVA Company profile

MetaVia Inc., a clinical-stage biotechnology company focuses on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases. It develops DA-1241, a…

MetaVia Inc., a clinical-stage biotechnology company focuses on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases. It develops DA-1241, a novel G-Protein-Coupled Receptor 119 agonist with development optionality as a standalone and/or combination therapy that is in Phase 2a clinical trial for metabolic dysfunction-associated steatohepatitis (MASH),…

MTVA Management team

Name

Position

Mi-Kyung Kim

Chief Scientific Officer

Marshall H. WoodworthCFO

Chief Financial Officer

Heon Kim HyungCEO

Chief Executive Officer, President & Director

Robert Homolka

Senior Vice President of Clinical Operations

W. Christopher Fang M.D.

Consulting Chief Medical Officer & Advisor

Name

Position

Mi-Kyung Kim

Chief Scientific Officer

Marshall H. WoodworthCFO

Chief Financial Officer

Heon Kim HyungCEO

Chief Executive Officer, President & Director

Robert Homolka

Senior Vice President of Clinical Operations

W. Christopher Fang M.D.

Consulting Chief Medical Officer & Advisor

Management Team

Mi-Kyung Kim

Chief Scientific Officer

Marshall H. WoodworthCFO

Chief Financial Officer

Heon Kim HyungCEO

Chief Executive Officer, President & Director

Robert Homolka

Senior Vice President of Clinical Operations

W. Christopher Fang M.D.

Consulting Chief Medical Officer & Advisor

Management

Mi-Kyung Kim

Chief Scientific Officer

Marshall H. WoodworthCFO

Chief Financial Officer

Heon Kim HyungCEO

Chief Executive Officer, President & Director

Robert Homolka

Senior Vice President of Clinical Operations

W. Christopher Fang M.D.

Consulting Chief Medical Officer & Advisor

Total 5 executives

MTVA Frequently asked questions

What is MetaVia Inc. (MTVA) Stock Price?

Current stock price of MetaVia Inc. (MTVA) stock is $1.820. The stock price is +5.81% higher in the session. The intraday range can be seen from this page. Volume of MetaVia Inc. (MTVA) stock is 79.42K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the MetaVia Inc. (MTVA) stock price going up or down today?

The stock price of MetaVia Inc. (MTVA) can change with earnings, company news, and overall market sentiment. MetaVia Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the MetaVia Inc. stock expensive at its current price?

Whether MetaVia Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for MTVA on this page is -1.15. EPS on this page is -1.58. Compare those figures with peers and growth expectations before deciding if the current MetaVia Inc. price is justified.

How has the stock price of MetaVia Inc. (MTVA) performed historically?

Historical performance for MetaVia Inc. (MTVA) is shown on the price chart on this page. Review multi-period moves alongside volume to see how MTVA reacted to past earnings and market events.

Should I buy MetaVia Inc. (MTVA) stock, at this price?

Buying MetaVia Inc. (MTVA) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.